Simplex Trading
RVMD icon

Simplex Trading’s Revolution Medicines RVMD Stock Holding History

Simplex Trading’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.76M Buy
48,900
+34,200
+233% +$3.45M ﹤0.01% 1151
2025
Q4 		$1.17M Sell
14,700
-4,300
-23% -$282K ﹤0.01% 2470
2025
Q3 		$887K Buy
19,000
+4,900
+35% +$192K ﹤0.01% 3178
2025
Q2 		$518K Buy
14,100
+6,500
+86% +$250K ﹤0.01% 3475
2025
Q1 		$268K Sell
7,600
-22,800
-75% -$925K ﹤0.01% 4035
2024
Q4 		$1.33M Buy
30,400
+27,500
+948% +$1.39M ﹤0.01% 2570
2024
Q3 		$131K Buy
2,900
+1,500
+107% +$65.3K ﹤0.01% 4952
2024
Q2 		$54K Sell
1,400
-2,400
-63% -$89.7K ﹤0.01% 6010
2024
Q1 		$122K Sell
3,800
-3,400
-47% -$101K ﹤0.01% 5381
2023
Q4 		$206K Sell
7,200
-20,300
-74% -$488K ﹤0.01% 4660
2023
Q3 		$761K Buy
27,500
+26,300
+2,192% +$780K ﹤0.01% 2953
2023
Q2 		$32K Sell
1,200
-2,000
-63% -$49.1K ﹤0.01% 6302
2023
Q1 		$69K Buy
+3,200
New +$78.8K ﹤0.01% 5568
2022
Q3 		– Sell
-200
Closed -$3K – 10756
2022
Q2 		$3K Sell
200
-100
-33% -$1.95K ﹤0.01% 9197
2022
Q1 		$7K Sell
300
-36,000
-99% -$784K ﹤0.01% 9199
2021
Q4 		$913K Buy
36,300
+35,700
+5,950% +$1.01M ﹤0.01% 2987
2021
Q3 		$20K Hold
600
– – ﹤0.01% 8451
2021
Q2 		$19K Buy
600
+578
+2,627% +$20.2K ﹤0.01% 8636
2021
Q1 		$100K Buy
22
+16
+267% +$717 ﹤0.01% 5752
2020
Q4 		$23K Buy
+6
New +$237 ﹤0.01% 6882

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Simplex Trading's RVMD Position: Q1 2026 in Review

Simplex Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 9,644 shares — an estimated $974K sold.

Simplex Trading first reported a position in RVMD in Q4 2020 and held it in 13 quarters. The position peaked at $768K in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Simplex Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,644 Revolution Medicines shares in Q1 2026, an estimated $974K.
  • Simplex Trading first reported a position in Revolution Medicines in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Revolution Medicines position peaked at $768K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.